The previous study of Cardet RF et al. [142] assessed the costs and diagnostic accuracy associated with using 68Ga-PSMA-11 PET/CT compared with CI in staging high-risk PCa use of information collected as part of the proPSMA study [70]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.